This is an X-PIL, which is a text only patient information leaflet, designed for people with sight problems.
Table of Contents
NEBILET 5 mg tablets
Nebivolol
1. What Nebilet is and what it is used for 2. Before you take Nebilet 3. How to take Nebilet 4. Possible side effects 5. How to store Nebilet 6. Further information
Nebilet contains nebivolol, a cardiovascular drug belonging to the group of selective beta-blocking agents (i.e. with a selective action on the cardiovascular system). It prevents increased heart rate, controls heart pumping strength. It also exerts a dilating action on blood vessels, which contributes as well to lower blood pressure.
It is used to treat raised blood pressure (hypertension).
Nebilet is also used to treat mild and moderate chronic heart failure in patients aged 70 or over, in addition to other therapies.
Inform your doctor if you have or develop one of the following problems:
If you have serious kidney problems do not take Nebilet for heart failure and tell your doctor.
You will be regularly monitored at the beginning of your treatment for chronic heart failure by an experienced physician (see section 3).
This treatment should not be stopped abruptly unless clearly indicated and evaluated by your doctor (see section 3).
Because of the lack of data on the use of the product in children and adolescents, Nebilet is not recommended for use in them.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. Certain medicines cannot be used at the same time, while other drugs require specific changes (in the dose, for example).
Always tell your doctor if you are using or receiving any of the following medicines in addition to Nebilet:
All these drugs as well as nebivolol may influence the blood pressure and/or heart function.
Nebilet can be taken with food or on an empty stomach, but the tablet is best taken with some water.
Nebilet should not be used during pregnancy, unless clearly necessary.
It is not recommended for use while breast-feeding.
Ask your doctor or pharmacist for advice before taking any medicine.
This medicine may cause dizziness or fatigue. If affected, do not drive or operate machinery.
This product contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Always take Nebilet exactly as your doctor has told you. You should check with your doctor if you are not sure.
Nebilet may be taken before, during or after the meal, but, alternatively, you can take it independently of meals. The tablet is best taken with some water.
If you have been told by your doctor to take ¼ (quarter) or ½ (half) tablet daily, please refer to the instructions below on how to break Nebilet 5 mg cross-scored tablets.
Diagrams 1 and 2: Easy breaking of the Nebivolol 5 mg cross-scored tablet in half.
Diagrams 3 and 4: Easy breaking of half of the Nebivolol 5 mg cross-scored tablet into quarters.
If you accidentally take an overdose of this medicine, tell your doctor of pharmacist immediately. The most frequent symptoms and signs of a Nebilet overdose are very slow heart beat (bradycardia), low blood pressure with possible fainting (hypotension), breathlessness such as in asthma (bronchospasm), and acute heart failure.
You can take activated charcoal (which is available at your pharmacy) while you wait for the arrival of the doctor.
If you forget a dose of Nebilet, but remember a little later on that you should have taken it, take that day’s dose as usual. However, if a long delay has occurred (e.g. several hours), so that the next due dose is near, skip the forgotten dose and take the next, scheduled, normal dose at the usual time. Do not take a double dose. Repeated skipping, however, should be avoided.
You should always consult with your doctor before stopping Nebilet treatment, whether you are taking it for high blood pressure or chronic heart failure.
You should not stop Nebilet treatment abruptly as this can temporarily make your heart failure worse. If it is necessary to stop Nebilet treatment for chronic heart failure, the daily dose should be decreased gradually, by halving the dose, at weekly intervals.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, Nebilet can cause side effects, although not everybody gets them.
When Nebilet is used for the treatment of raised blood pressure, the possible side effects are:
Common side effects (more than 1 person in every 100 treated but fewer than 1 person in every 10 treated):
Uncommon side effects (more than 1 person in every 1,000 treated, but fewer than 1 person in every 100 treated):
Very rare side effects (fewer than 1 person in every 10,000 treated):
The following side effects have been reported only in some isolated cases during Nebilet treatment:
In a clinical study for chronic heart failure, the following side effects were seen:
Very common side effects (more than 1 person in every 10 treated):
Common side effects (more than 1 person in every 100 but less than 1 person in every 10 treated):
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Keep out of the reach and sight of children.
This medicinal product does not require any special storage conditions. Do not take Nebilet after the expiry date which is stated on the carton label and blister foil after EXP. The expiry date refers to the last day of that month.
Nebilet should not be disposed of via wastewater or household waste.
Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
Nebilet is available as white, round, cross-scored tablets in packs of 7, 14, 28, 30, 50, 56, 90, 100, 500 tablets. Tablets are provided in blister packs (PVC/aluminium blister).
(Not all pack sizes may be marketed)
or
This medicinal product is authorised in the Member States of the EEA under the following names:
Austria: Nomexor
Belgium: Hypoloc
Denmark: Nebilet
Finland: Nebilet
France: Hypoloc
Germany: Hypoloc
Greece: Hypoloc
Ireland: Nebilet
Italy: Lobivon
Iceland: Hypoloc
Luxembourg: Hypoloc
Norway: Hypoloc
Portugal: Hypoloc
Spain: Silostar
The Netherlands: Hypoloc
United Kingdom: Nebilet
This leaflet was last approved in 12/2011.
Link to this document from your website:http://www.medicines.ie/medicine/7903/XPIL/Nebilet/